Similar Search Results - EconBiz

Impacts of patent expiry and regulatory policies on daily cost of pharmaceutical treatments : OECD countries, 2004 - 2010

Berndt, Ernst R.; Dubois, Pierre - 2012

Persistent link: https://www.econbiz.de/10009578828

The effect of FDA advisories on branded pharmaceutical firms' valuations and promotion efforts

Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - 2011

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of...

Persistent link: https://www.econbiz.de/10009374023

Quality adjustment for health care spending on chronic disease : evidence from diabetes treatment, 1999 - 2009

Eggleston, Karen; Shah, Nilay D.; Smith, Steven A.; … - In: The American economic review 101 (2011) 3, pp. 206-211

Persistent link: https://www.econbiz.de/10009261814

Price indexes for clinical trial research : a feasibility study

Berndt, Ernst R.; Cockburn, Iain - 2013

Persistent link: https://www.econbiz.de/10009735806

Characterizing markets for biopharmaceutical innovations : do biologics differ from small molecules?

Trusheim, Mark R.; Aitken, Murray L.; Berndt, Ernst R. - In: Forum for health economics & policy : an evolving … 13 (2010) 1, pp. 1-43

Persistent link: https://www.econbiz.de/10009616664

A primer on the economics of prescription pharmaceutical pricing in health insurance markets

Berndt, Ernst R.; McGuire, Thomas G.; Newhouse, Joseph P. - In: Forum for health economics & policy : an evolving … 14 (2011) 2, pp. 1-28

Persistent link: https://www.econbiz.de/10009620010

Specialty drug prices and utilization after loss of US patent exclusivity, 2001 - 2007

Conti, Rena M.; Berndt, Ernst R. - 2014

Persistent link: https://www.econbiz.de/10010352001

The regulation of prescription drug competition and market responses : patterns in prices and sales following loss of exclusivity

Aitken, Murray L.; Berndt, Ernst R.; Bosworth, Barry; … - 2013

Persistent link: https://www.econbiz.de/10010198694

The heterogeneity of concentrated prescribing behavior : theory and evidence from antipsychotics

Berndt, Ernst R.; Gibbons, Robert; Kolotilin, Anton; … - In: Journal of health economics 40 (2015), pp. 26-39

Persistent link: https://www.econbiz.de/10011439946

Cost-benefit analysis of the FDA : the case of the Prescription Drug User Fee Acts

Philipson, Tomas J.; Berndt, Ernst R.; Gottschalk, … - 2007

Persistent link: https://www.econbiz.de/10010434769

A service of the